BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 16608856)

  • 41. Estrogen-induced c-fos protooncogene expression in MCF-7 human breast cancer cells: role of estrogen receptor Sp1 complex formation.
    Duan R; Porter W; Safe S
    Endocrinology; 1998 Apr; 139(4):1981-90. PubMed ID: 9528985
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Silencing of transcription of the human luteinizing hormone receptor gene by histone deacetylase-mSin3A complex.
    Zhang Y; Dufau ML
    J Biol Chem; 2002 Sep; 277(36):33431-8. PubMed ID: 12091390
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Estrogen-induced and TAFII30-mediated gene repression by direct recruitment of the estrogen receptor and co-repressors to the core promoter and its reversal by tamoxifen.
    Hao H; d'Alincourt-Salazar M; Kelley KM; Shatnawi A; Mukherjee S; Shah YM; Ratnam M
    Oncogene; 2007 Dec; 26(57):7872-84. PubMed ID: 17599049
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Down-modulation of interleukin-6 gene expression by 17 beta-estradiol in the absence of high affinity DNA binding by the estrogen receptor.
    Ray A; Prefontaine KE; Ray P
    J Biol Chem; 1994 Apr; 269(17):12940-6. PubMed ID: 8175711
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transcriptional activation of E2F1 gene expression by 17beta-estradiol in MCF-7 cells is regulated by NF-Y-Sp1/estrogen receptor interactions.
    Wang W; Dong L; Saville B; Safe S
    Mol Endocrinol; 1999 Aug; 13(8):1373-87. PubMed ID: 10446910
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Estrogen regulation of chicken riboflavin carrier protein gene is mediated by ERE half sites without direct binding of estrogen receptor.
    Bahadur U; Ganjam GK; Vasudevan N; Kondaiah P
    Mol Cell Endocrinol; 2005 Feb; 231(1-2):1-11. PubMed ID: 15713531
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Estrogen receptor beta activates the human retinoic acid receptor alpha-1 promoter in response to tamoxifen and other estrogen receptor antagonists, but not in response to estrogen.
    Zou A; Marschke KB; Arnold KE; Berger EM; Fitzgerald P; Mais DE; Allegretto EA
    Mol Endocrinol; 1999 Mar; 13(3):418-30. PubMed ID: 10076999
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of transcriptional regulatory elements in the human somatostatin receptor sst2 promoter and regions including estrogen response element half-site for estrogen activation.
    Kimura N; Takamatsu N; Yaoita Y; Osamura RY; Kimura N
    J Mol Endocrinol; 2008 Feb; 40(2):75-91. PubMed ID: 18234910
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Functional and physical interactions between the estrogen receptor Sp1 and nuclear aryl hydrocarbon receptor complexes.
    Wang F; Hoivik D; Pollenz R; Safe S
    Nucleic Acids Res; 1998 Jun; 26(12):3044-52. PubMed ID: 9611253
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Kruppel-like factor 9 is a negative regulator of ligand-dependent estrogen receptor alpha signaling in Ishikawa endometrial adenocarcinoma cells.
    Velarde MC; Zeng Z; McQuown JR; Simmen FA; Simmen RC
    Mol Endocrinol; 2007 Dec; 21(12):2988-3001. PubMed ID: 17717078
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transcription factor accessibility and histone acetylation of the progesterone receptor gene differs between parental MCF-7 cells and a subline that has lost progesterone receptor expression.
    Xu X; Murdoch FE; Curran EM; Welshons WV; Fritsch MK
    Gene; 2004 Mar; 328():143-51. PubMed ID: 15019994
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A transcriptionally active estrogen receptor mutant is a novel type of dominant negative inhibitor of estrogen action.
    McInerney EM; Ince BA; Shapiro DJ; Katzenellenbogen BS
    Mol Endocrinol; 1996 Dec; 10(12):1519-26. PubMed ID: 8961262
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Global gene expression analysis of estrogen receptor transcription factor cross talk in breast cancer: identification of estrogen-induced/activator protein-1-dependent genes.
    DeNardo DG; Kim HT; Hilsenbeck S; Cuba V; Tsimelzon A; Brown PH
    Mol Endocrinol; 2005 Feb; 19(2):362-78. PubMed ID: 15514030
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The tumor suppressor p53 and histone deacetylase 1 are antagonistic regulators of the cyclin-dependent kinase inhibitor p21/WAF1/CIP1 gene.
    Lagger G; Doetzlhofer A; Schuettengruber B; Haidweger E; Simboeck E; Tischler J; Chiocca S; Suske G; Rotheneder H; Wintersberger E; Seiser C
    Mol Cell Biol; 2003 Apr; 23(8):2669-79. PubMed ID: 12665570
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cell cycle regulatory effects of retinoic Acid and forskolin are mediated by the cyclin C gene.
    Makkonen KM; Malinen M; Ropponen A; Väisänen S; Carlberg C
    J Mol Biol; 2009 Oct; 393(2):261-71. PubMed ID: 19683536
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transcription factor FBI-1 acts as a dual regulator in adipogenesis by coordinated regulation of cyclin-A and E2F-4.
    Laudes M; Bilkovski R; Oberhauser F; Droste A; Gomolka M; Leeser U; Udelhoven M; Krone W
    J Mol Med (Berl); 2008 May; 86(5):597-608. PubMed ID: 18368381
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A novel functional interaction between the Sp1-like protein KLF13 and SREBP-Sp1 activation complex underlies regulation of low density lipoprotein receptor promoter function.
    Natesampillai S; Fernandez-Zapico ME; Urrutia R; Veldhuis JD
    J Biol Chem; 2006 Feb; 281(6):3040-7. PubMed ID: 16303770
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A fusion protein of the estrogen receptor (ER) and nuclear receptor corepressor (NCoR) strongly inhibits estrogen-dependent responses in breast cancer cells.
    Chien PY; Ito M; Park Y; Tagami T; Gehm BD; Jameson JL
    Mol Endocrinol; 1999 Dec; 13(12):2122-36. PubMed ID: 10598586
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transcriptional regulation of mixed lineage kinase 3 by estrogen and its implication in ER-positive breast cancer pathogenesis.
    Viswakarma N; Nair RS; Sondarva G; Das S; Ibrahimi L; Chen Z; Sinha S; Rana B; Rana A
    Oncotarget; 2017 May; 8(20):33172-33184. PubMed ID: 28388540
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of estrogen-responsive gene activation by the retinoid X receptor beta: evidence for multiple inhibitory pathways.
    Segars JH; Marks MS; Hirschfeld S; Driggers PH; Martinez E; Grippo JF; Brown M; Wahli W; Ozato K
    Mol Cell Biol; 1993 Apr; 13(4):2258-68. PubMed ID: 8384307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.